Biochemistry and Molecular Biology Unit, Department of Biomedical Sciences, School of Medicine, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Catalonia, Spain.
Nanologica AB, Södertälje, Sweden.
Nanomedicine (Lond). 2022 Jun;17(15):1077-1094. doi: 10.2217/nnm-2022-0026. Epub 2022 Aug 23.
Mesoporous silica particles (MSPs) are broadly used drug delivery carriers. In this study, the authors analyzed the responses to MSPs of astrocytes and microglia, the two main cellular players in neuroinflammation. Primary murine cortical mixed glial cultures were treated with rhodamine B-labeled MSPs. MSPs are avidly internalized by microglial cells and remain inside the cells for at least 14 days. Despite this, MSPs do not affect glial cell viability or morphology, basal metabolic activity or oxidative stress. MSPs also do not affect mRNA levels of key proinflammatory genes; however, in combination with lipopolysaccharide, they significantly increase extracellular IL-1β levels. These results suggest that MSPs could be novel tools for specific drug delivery to microglial cells.
介孔硅颗粒(MSPs)被广泛用作药物传递载体。在这项研究中,作者分析了星形胶质细胞和小胶质细胞对 MSPs 的反应,这两种细胞是神经炎症的主要细胞参与者。原代鼠皮质混合神经胶质细胞培养物用罗丹明 B 标记的 MSPs 处理。MSPs 被小胶质细胞强烈内化,并至少在细胞内保留 14 天。尽管如此,MSPs 并不影响神经胶质细胞的活力或形态、基础代谢活性或氧化应激。MSPs 也不影响关键促炎基因的 mRNA 水平;然而,与脂多糖联合使用时,它们显著增加了细胞外的 IL-1β 水平。这些结果表明,MSPs 可能成为向小胶质细胞特异性递药的新型工具。